Brief: Keros Therapeutics Announces Additional Update On The Phase 2 Tropos Trial
15/01/2025 12:05
Jan 15 (Reuters) - Keros Therapeutics Inc KROS.O :
* KEROS THERAPEUTICS ANNOUNCES ADDITIONAL UPDATE ON THE
PHASE 2
TROPOS TRIAL
* HALTS ALL DOSING IN TROPOS TRIAL DUE TO SAFETY REVIEW
* EXPECTS TO PRESENT TOPLINE DATA IN Q2 2025
* TROPOS TRIAL TERMINATED EARLY, PATIENTS TO BE MONITORED
Source text: ID:nGNX4tY1PN
Further company coverage: KROS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Keros Therapeutics
See all newsBrief: Keros Therapeutics May Offer Up To $350 Million Of Securities - SEC Filing
Keros Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Keros Therapeutics Q2 net loss narrows on lower expenses
Brief: Keros Therapeutics - Keith Regnante Resigns As CFO
Keros Therapeutics posts Q1 net loss as license revenue drops